Neha Shrestha
Neha Shrestha
Senior Researcher
Verified email at uclouvain.be
Title
Cited by
Cited by
Year
The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
F Araújo, N Shrestha, MA Shahbazi, P Fonte, EM Mäkilä, JJ Salonen, ...
Biomaterials 35 (33), 9199-9207, 2014
1112014
Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
M Lopes, N Shrestha, A Correia, MA Shahbazi, B Sarmento, J Hirvonen, ...
Journal of controlled release 232, 29-41, 2016
1022016
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
N Shrestha, MA Shahbazi, F Araújo, H Zhang, EM Mäkilä, J Kauppila, ...
Biomaterials 35 (25), 7172-7179, 2014
922014
Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs
F Araujo, N Shrestha, MA Shahbazi, D Liu, B Herranz-Blanco, EM Makila, ...
ACS nano 9 (8), 8291-8302, 2015
772015
Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
B Herranz-Blanco, LR Arriaga, E Mäkilä, A Correia, N Shrestha, S Mirza, ...
Lab on a Chip 14 (6), 1083-1086, 2014
682014
Thiolation and cell‐penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, ...
Advanced Functional Materials 26 (20), 3405-3416, 2016
642016
Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: a controlled dual protein-drug delivery system
N Shrestha, MA Shahbazi, F Araújo, E Mäkilä, J Raula, EI Kauppinen, ...
Biomaterials 68, 9-20, 2015
562015
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
522019
A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
MA Shahbazi, N Shrestha, E Mäkilä, F Araújo, A Correia, T Ramos, ...
Nano Research 8 (5), 1505-1521, 2015
432015
PEG-PGA enveloped octaarginine-peptide nanocomplexes: an oral peptide delivery strategy
Z Niu, E Samaridou, E Jaumain, J Coëne, G Ullio, N Shrestha, J Garcia, ...
Journal of controlled release 276, 125-139, 2018
362018
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
F Araujo, N Shrestha, MJ Gomes, B Herranz-Blanco, D Liu, JJ Hirvonen, ...
Nanoscale 8 (20), 10706-10713, 2016
312016
Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
F Araújo, N Shrestha, PL Granja, J Hirvonen, HA Santos, B Sarmento
Expert opinion on drug metabolism & toxicology 11 (3), 381-393, 2015
302015
Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, M Airavaara, ...
Journal of Controlled Release 232, 113-119, 2016
292016
Spray drying of fenofibrate loaded nanostructured lipid carriers
D Xia, N Shrestha, J van de Streek, H Mu, M Yang
asian journal of pharmaceutical sciences 11 (4), 507-515, 2016
252016
Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
MA Shahbazi, PV Almeida, A Correia, B Herranz-Blanco, N Shrestha, ...
Journal of Controlled Release 249, 111-122, 2017
232017
Influence of surface chemistry on ibuprofen adsorption and confinement in mesoporous silicon microparticles
E Mäkilä, H Kivelä, N Shrestha, A Correia, M Kaasalainen, E Kukk, ...
Langmuir 32 (49), 13020-13029, 2016
172016
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers
N Shrestha, O Bouttefeux, K Vanvarenberg, P Lundquist, J Cunarro, ...
Nanoscale, 2018
162018
Antihyperglycemic potential of incretins orally delivered via nano and microsystems and subsequent glucoregulatory effects
F Araujo, N Shrestha, P L Granja, J Hirvonen, H A Santos, B Sarmento
Current Pharmaceutical Biotechnology 15 (7), 609-619, 2014
112014
Cell-based In Vitro Models for Buccal Permeability Studies
N Shrestha, F Araújo, B Sarmento, J Hirvonen, H Santos
Concepts and Models for Drug Permeability Studies, B. Sarmento, 2015
82015
Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems
Y Xu, N Shrestha, V Préat, A Beloqui
Journal of Controlled Release, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20